Generation Lab
Burlingame, US · Founded 2023 · 29 employees on LinkedIn · 14 known investors
Find your way into Generation Lab
2,577 people in our graph share verified history with the Generation Lab team — schools, employers, funds. One of them is your warm intro.
.jpeg)
Generation Lab offers an at-home epigenetic aging test (SystemAge) that measures 460 biomarkers across 21 organs and systems using DNA methylation, delivering a personalized aging report and action plan for consumers. It uses a needle-free blood collection device and connects users to a network of longevity clinics for follow-up consultations and retesting.
Also known as Generation Lab
Founders & leadership
Generation Lab was founded in 2023 by Irina Conboy, Alina Su, and Michael Suswal.
Investors · 14
Also in the syndicate · 4
Funding
SEC filings, press & company announcements$11M disclosed across 1 of 2 rounds · 2024–2025
- $11MSeed FundingOct 2025 · 10 sources
Accel (lead), Aoki Labs, Build Your Legacy (BYL) Ventures, Build Your Legacy Ventures, BYL Ventures, Markham Valley Ventures, Samsung Next, Zone2
Source ↗ - Undisclosed amountpre-seedJan 2024 · 2 sources
Sequoia China, Transpose Platform
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Company profile
researched Aug 2026Generation Lab is a San Francisco-based longevity diagnostics company built around SystemAge, a biological-age test derived from DNA methylation in primary blood samples. The company describes the test as quantifying the health of 19 organ systems and functions — including cardiovascular, reproductive, immune, fibrotic, metabolic and regenerative systems — and its consumer site describes coverage of 460 biomarkers across 21 organs and systems; Fortune's account describes 460 biomarkers across 19 organs and systems. Results are delivered as a SystemAge report with a personalized action plan, followed by consultation with practitioners and retesting.
The consumer workflow is an at-home blood collection kit using a needle-free device that the company says takes about 15 minutes, after which users receive their report and can locate an affiliated clinic through the company's provider network. On the clinical side, the platform is positioned for use in academic medical centers, performance medicine practices and wellness clinics. The company states the approach is based on a discovered physiologic non-linear curve of DNA methylation aging, in contrast with correlative "biological clock" models, and that proprietary algorithms trained on hundreds of millions of data points identify which systems are aging fastest and support intervention strategies.
Generation Lab reports clinical observations associated with its testing, including 13.6 years of brain-age reversal and 4.9 years of reproductive-system age reversal measured before and after MUSE stem cell treatment, and measurable changes in heart and immune system biological age from anti-inflammatory diets, fasting protocols and exercise regimens. It also reports that 70% of tested individuals were biologically older than their chronological age.
Founding story
According to Fortune, Generation Lab was started in 2023 by Alina Su, UC Berkeley professor Dr. Irina Conboy and Michael Suswal, a founding team spanning three generations — Conboy a Baby Boomer known for cell regeneration and parabiosis research, Suswal a millennial who previously co-founded Standard AI, and Su, then a Berkeley undergraduate who sought out Conboy. The team frames its goal as an "ageless generation" and adding roughly 20 healthy years to life.
Business model
Generation Lab sells the SystemAge test both directly to consumers via an at-home collection kit and through a partner network of longevity, performance medicine and wellness clinics that order the diagnostic for their patients. Follow-on consultation and retesting are part of the described product path.
Test sales: Fortune reports the test costs $490, with additional subscription-based testing options.
Traction
Within less than a year of launch the company reported 275+ clinic partners worldwide (Fortune: 300+ partners across 18 countries), more than 300 million human-aging data points, and tens of thousands of users. The company's website cites 750+ clinics and 1,000+ practitioners.
Latest developments
On October 23, 2025, Generation Lab announced an $11 million seed round led by Accel with participation from Samsung Next, Zone2, Aoki Labs, BYL Ventures and Markham Valley Ventures, bringing total funding to $15 million. Proceeds are earmarked for expanding clinic adoption of SystemAge, operations and product development, plus continued clinical research validating the platform.
▸Full profile — market position, technology, go-to-market, geography, history, risks & controversies
Market position
Positioned as a longevity diagnostics provider in a growing consumer and clinical longevity market; Accel described the investment as its first bet in the longevity space, and the company characterizes its $11M seed as being in the top 1% of startup seed raises.
The company contrasts SystemAge with correlative "biological clock" models that it says transform data in a biologically arbitrary way and carry large errors, arguing that its system-level measurement from intact primary data detects dysregulation before symptoms appear and identifies which specific organ systems are aging fastest, rather than reporting a single aggregate age or disease biomarkers.
Technology
DNA methylation-based epigenetic analysis of intact primary blood data, built on what the company describes as the discovery of the physiologic non-linear curve of DNA methylation aging and a systems-based measure of "biological noise." Proprietary algorithms trained on more than 300 million human-aging data points score aging across 19 physiological systems; the company claims 99.9% diagnostic accuracy. Sample collection uses a needle-free, at-home blood collection device.
Go-to-market
A dual channel of direct consumer sales through its website and clinic partnerships; the company reported growth from zero to more than 275 clinic partners in under a year, with Fortune citing more than 300 clinic partners in 18 countries. Adoption is promoted through longevity physicians, professional athletes and celebrities, and the company cites early advocates including David Sinclair, George Church, Adeel Khan, Michael Roizen and Aubrey de Grey.
Consumers seeking preventive health and biological-age measurement, and clinicians in longevity, performance medicine, wellness and academic medical settings; users also include professional athletes and celebrities.
Geography
Headquartered in San Francisco, California, with clinic partners worldwide; Fortune reports availability through more than 300 clinic partners across 18 countries.
History
Founded in 2023 and headquartered in San Francisco, the company launched its SystemAge diagnostic and within under a year signed more than 275 clinic partners. On October 23, 2025 it announced an $11 million seed round led by Accel, bringing total funding to $15 million.
Risks & controversies
Performance and accuracy claims — including 99.9% diagnostic accuracy, years of measured organ-age reversal after MUSE stem cell treatment, and comparisons against other biological clocks — originate from the company itself. Fortune notes the $490 test price is cost-prohibitive for most consumers. Published figures also vary across sources, with the company site citing 460 biomarkers across 21 organs and systems and 750+ clinics while the funding announcement cites 19 systems and 275+ clinics.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 1
launches, deals, and filingsGeneration Lab announced an $11 million seed round led by Accel, with participation from Samsung Next, Zone2, Steve Aoki's Aoki Labs, Giannis Antetokounmpo's Build Your Legacy Ventures and Simu Liu's Markham Valley Ventures, bringing total funding to $15 million. Funds are to be used to expand adoption of the SystemAge diagnostic, operations and development. Accel described it as its first longevity investment.
$11M source ↗
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
In the news
▸Research sources · 8
primary sources listed
- Generation Labgenerationlab.com · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Generation Lab do?
- San Francisco longevity diagnostics company whose SystemAge epigenetic blood test measures biological aging across organ systems.
- Who founded Generation Lab?
- Generation Lab was founded by Irina Conboy, Alina Su, Michael Suswal in 2023.
- Who are Generation Lab's investors?
- Generation Lab's investors include Accel, Berkeley Frontier, Coral Capital, MARKHAM VALLEY VENTURES, Samsung Next, SLVC, Transpose Platform Management, Zone 2 Ventures Llc and 2 more.
- How much funding has Generation Lab raised?
- Generation Lab has disclosed $11M raised across 1 of its 2 known rounds.
- Where is Generation Lab headquartered?
- Generation Lab is headquartered in Burlingame, US.